High purity heparin and production method therefor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9540454
APP PUB NO 20150094460A1
SERIAL NO

14565671

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a high purity heparin useful to be a pharmaceutical product, cosmetics, research reagent, or the like, and a method for producing the same, more specifically, a heparin which does not substantially contain a nitrous acid degradation-resistant impurity and a method for producing a heparin, comprising mixing an aqueous solution of 5 to 30% by weight of the heparin with ethanol having an amount (volume) 0.2 to 1 times the amount (volume) of the aqueous heparin solution to obtain a colloidal precipitate of heparin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FUSO PHARMACEUTICAL INDUSTRIES LTDOSAKA-SHI OSAKA 541-0045
UNIVERSITY OF MIYAZAKIMIYAZAKI-SHI MIYAZAKI 889-2192

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Muguruma, Michio Miyazaki, JP 2 0
Murata, Hiroshi Osaka, JP 146 1204

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 10, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00